| Literature DB >> 34659415 |
Farshid Rafiee Sarbijan Nasab1, Parvin Mangolian Shahrbabaki1,2, Mahlagha Dehghan1,2, Haleh Tajadini3, Hamideh Baniasadi1, Sakineh Sabzevari1,4.
Abstract
OBJECTIVE: The aim of this study was to determine the effect of abdominal massage with and without Salvia officinalis on nausea and vomiting in patients with cancer undergoing chemotherapy.Entities:
Year: 2021 PMID: 34659415 PMCID: PMC8514906 DOI: 10.1155/2021/9989228
Source DB: PubMed Journal: J Oncol ISSN: 1687-8450 Impact factor: 4.375
Figure 1The study flow diagram.
Description of participations/clinical information in three study groups.
| Variables | Group | |||||||
|---|---|---|---|---|---|---|---|---|
| The AM with AS group | The AM without AS group | The control group | Statistical analysis |
| ||||
| Mean | SD | Mean | SD | Mean | SD | |||
| Duration of cancer (months) | 8.95 | 6.50 | 8.25 | 4.55 | 8.25 | 6.73 |
| 0.91 |
| Duration of chemotherapy (months) | 5.70 | 4.11 | 6.90 | 4.61 | 6.70 | 6.21 |
| 0.72 |
| Weight (kg) | 62.60 | 13.57 | 63.75 | 11.06 | 63.95 | 12.90 |
| 0.94 |
|
| % |
| % |
| % | |||
| Type of cancer | ||||||||
| Breast | 7 | 35.0 | 4 | 20.0 | 4 | 20.0 |
| 0.62 |
| Blood | 2 | 10.0 | 2 | 10.0 | 2 | 10.0 | ||
| Respiratory tract | 2 | 10.0 | 4 | 20.0 | 2 | 10.0 | ||
| Gastrointestinal | 4 | 20.0 | 4 | 20.0 | 5 | 25.0 | ||
| Reproductive | 2 | 10.0 | 4 | 20.0 | 1 | 5.0 | ||
| Others | 3 | 15.0 | 1 | 5.0 | 6 | 30.0 | ||
| Other cancer treatments | ||||||||
| No | 7 | 35.0 | 9 | 45.0 | 10 | 50.0 | Fisher's exact test = 4.22 | 0.65 |
| Surgery | 8 | 40.0 | 8 | 40.0 | 9 | 45.0 | ||
| Radiotherapy | 2 | 10.0 | 2 | 10.0 | 0 | 0 | ||
| Surgery and radiotherapy | 3 | 15.0 | 1 | 5.0 | 1 | 5.0 | ||
| Other underlying diseases | ||||||||
| No | 18 | 90.0 | 19 | 95.0 | 19 | 95.0 |
| 0.76 |
| Yes | 2 | 10.0 | 1 | 5.0 | 1 | 5.0 | ||
Melanoma, lymphoma, and pancreatic cancer. Diabetes and hypertension. AM: abdominal massage; AS: aromatic substance; SD: standard deviation; F: analysis of variance.
Comparison of the drug type received by the patient in the three study groups.
| Variables | Group | |||||||
|---|---|---|---|---|---|---|---|---|
| The AM with AS group | The AM without AS group | The control group | Statistical analysis |
| ||||
| n | % | n | % | n | % | |||
| Opium | ||||||||
| Yes | 4 | 20.0 | 5 | 25.0 | 5 | 25.0 |
| 0.91 |
| No | 16 | 80.0 | 15 | 75.0 | 15 | 75.0 | ||
| Painkillers | ||||||||
| Yes | 9 | 45.0 | 8 | 40.0 | 8 | 40.0 |
| 0.93 |
| No | 11 | 55.0 | 12 | 60.0 | 12 | 60.0 | ||
| Digestive | ||||||||
| Yes | 9 | 45.0 | 9 | 45.0 | 5 | 25.0 |
| 0.32 |
| No | 11 | 55.0 | 11 | 55.0 | 15 | 75.0 | ||
| Carboplatin | ||||||||
| Yes | 2 | 10.0 | 2 | 10.0 | 1 | 5.0 |
| 0.80 |
| No | 18 | 90.0 | 18 | 90.0 | 19 | 95.0 | ||
| Cisplatin | ||||||||
| Yes | 4 | 20.0 | 3 | 15.0 | 3 | 15.0 |
| 0.89 |
| No | 16 | 80.0 | 17 | 85.0 | 17 | 85.0 | ||
| Doxorubicin | ||||||||
| Yes | 1 | 5.0 | 0 | 0.0 | 3 | 15.0 | Fisher's exact test = 3.11 | 0.31 |
| No | 19 | 95.0 | 20 | 100.0 | 17 | 85.0 | ||
| Endoxan | ||||||||
| Yes | 3 | 15.0 | 2 | 10.0 | 6 | 30.0 |
| 0.24 |
| No | 17 | 85.0 | 18 | 90.0 | 14 | 70.0 | ||
| Etoposide | ||||||||
| Yes | 2 | 10.0 | 1 | 5.0 | 1 | 5.0 |
| 0.76 |
| No | 18 | 90.0 | 19 | 95.0 | 19 | 95.0 | ||
| Fluorouracil | ||||||||
| Yes | 5 | 25.0 | 6 | 30.0 | 4 | 20.0 |
| 0.77 |
| No | 15 | 75.0 | 14 | 70.0 | 16 | 80.0 | ||
| Gemcitabine | ||||||||
| Yes | 2 | 10.0 | 3 | 15.0 | 1 | 5.0 |
| 0.86 |
| No | 18 | 90.0 | 17 | 85.0 | 19 | 95.0 | ||
| Herceptin | ||||||||
| Yes | 3 | 15.0 | 0 | 0.0 | 1 | 5.0 | Fisher's exact test = 3.11 | 0.31 |
| No | 17 | 85.0 | 20 | 100.0 | 19 | 95.0 | ||
| Irinotecan | ||||||||
| Yes | 1 | 5.0 | 2 | 10.0 | 1 | 5.0 |
| 0.76 |
| No | 19 | 95.0 | 18 | 90.0 | 19 | 95.0 | ||
| Leucovorin | ||||||||
| Yes | 2 | 10.0 | 2 | 10.0 | 3 | 15.0 |
| 0.85 |
| No | 18 | 90.0 | 18 | 90.0 | 17 | 85.0 | ||
| Oxaliplatin | ||||||||
| Yes | 1 | 5.0 | 1 | 5.0 | 2 | 10.0 |
| 0.76 |
| No | 19 | 95.0 | 19 | 95.0 | 18 | 90.0 | ||
| Paclitaxel | ||||||||
| Yes | 3 | 15.0 | 1 | 5.0 | 2 | 10.0 |
| 0.57 |
| No | 17 | 85.0 | 19 | 95.0 | 18 | 90.0 | ||
| Taxotere | ||||||||
| Yes | 2 | 10.0 | 1 | 5.0 | 1 | 5.0 |
| 0.76 |
| No | 18 | 90.0 | 19 | 95.0 | 19 | 95.0 | ||
| Zoladex | ||||||||
| Yes | 0 | 0.0 | 3 | 15.0 | 1 | 5.0 | Fisher's exact test = 3.11 | 0.31 |
| No | 20 | 100.0 | 17 | 85.0 | 19 | 95.0 | ||
| Other chemotherapy drugs | ||||||||
| Yes | 2 | 10.0 | 6 | 30.0 | 8 | 40.0 |
| 0.09 |
| No | 18 | 90.0 | 14 | 70.0 | 12 | 60.0 | ||
Methotrexate and bleomycin. AM: abdominal massage; AS: aromatic substance.
Comparison of the mean scores of nauseas at different times between the three groups.
| Variables | Group | |||||
|---|---|---|---|---|---|---|
| The AM with AS group | The AM without AS group | The control group | ||||
| Mean | SD | Mean | SD | Mean | SD | |
| Before the intervention | 4.85 | 2.62 | 4.80 | 2.75 | 4.60 | 2.46 |
| Immediately after the intervention | 1.80 | 1.67 | 2.85 | 2.01 | 3.65 | 1.60 |
| One week after the intervention | 0.25 | 0.44 | 0.95 | 1.05 | 1.80 | 1.10 |
| The source of change | Sums of squares | Degrees of freedom |
|
| Eta2 | |
| Group | 30.28 | 2 | 4.0 | 0.02 | 0.045 | |
| Time | 337.34 | 2 | 44.52 | <0.001 | 0.34 | |
| Group | 24.49 | 4 | 1.62 | 0.17 | 0.04 | |
| Error | 647.80 | 171 | ||||
AM: abdominal massage; AS: aromatic substance; SD: standard deviation; F: repeated-measures analysis of variance.
Results of post hoc Bonferroni tests on the comparison of changes in the mean scores of nausea at different times between the three groups.
| Time | Group (I) | Group (J) | Mean of changes (I−J) | Standard Error |
|
|---|---|---|---|---|---|
| Before the intervention | The AM with AS group | The AM without AS group | 0.05 | 0.62 | >0.99 |
| The control group | 0.25 | 0.62 | >0.99 | ||
| The AM without AS group | The control group | 0.20 | 0.62 | >0.99 | |
|
| |||||
| Immediately after the intervention | The AM with AS group | The AM without AS group | −1.05 | 0.62 | 0.27 |
| The control group | −1.85 | 0.62 | 0.009 | ||
| The AM without AS group | The control group | −0.8 | 0.62 | 0.59 | |
|
| |||||
| One week after the intervention | The AM with AS group | The AM without AS group | −0.75 | 0.62 | 0.67 |
| The control group | −1.40 | 0.62 | 0.07 | ||
| The AM without AS group | The control group | −0.65 | 0.62 | 0.88 | |
AM: abdominal massage; AS: aromatic substance.
Results of post hoc Bonferroni tests to compare the changes in the mean scores of nausea at different times within each group.
| Group | Time (I) | Time (J) | Mean of changes (I−J) | Standard error |
|
|---|---|---|---|---|---|
| The AM with AS group | Immediately after the intervention | Before the intervention | −3.05 | 0.62 | <0.001 |
| One week after the intervention | Before the intervention | −4.15 | 0.62 | <0.001 | |
| Immediately after the intervention | −1.1 | 0.62 | 0.23 | ||
|
| |||||
| The AM without AS group | Immediately after the intervention | Before the intervention | −1.95 | 0.62 | 0.005 |
| One week after the intervention | Before the intervention | −3.35 | 0.62 | <0.001 | |
| Immediately after the intervention | −1.40 | 0.62 | 0.07 | ||
|
| |||||
| The control group | Immediately after the intervention | Before the intervention | −0.95 | 0.62 | 0.37 |
| One week after the intervention | Before the intervention | −2.5 | 0.62 | <0.001 | |
| Immediately after the intervention | −1.5 | 0.62 | 0.04 | ||
AM: abdominal massage; AS: aromatic substance.